Identification of putative ligand-binding sites of the integrin α4β1 (VLA-4, CD49d/CD29)

T. Kamata, W. Puzon, Yoshikazu Takada

Research output: Contribution to journalArticle

115 Citations (Scopus)

Abstract

Integrin α4β1 recognizes both fibronectin (CS-1 sequence) and vascular cell adhesion molecule-1 (VCAM-1). To localize the ligand-binding sites of α4, we located the epitopes for function-blocking anti-α4 monoclonal antibodies (mAbs), including those that recognize previously described (but not yet physically localized) functional epitopes (A, B1, B2 and C) using interspecies α4 chimeras expressed in mammalian cells. Epitopes B1 and B2 were associated with ligand binding, and epitopes A and B2 with homotypic cellular aggregation, mAbs P4C2 (epitope B2), 20E4 and PS/2 were mapped within residues 108-182; mAbs HP2/1 (epitope B1), SG/73 and R1-2 within residues 195-268; mAbs HP1/3 (epitope A) and P4G9 within residues 1-38; and B5G10 (epitope C) within residues 269-548. The data suggest that residues 108-268, which do not include bivalent-cation-binding motifs, are related to VCAM-1 and CS-1 binding, and more N-terminal portions of α4 (residues 1-38 and 108-182) to homotypic aggregation. Since mAbs PS/2 and HP2/1 block α4β7 binding to mucosal addressin cell adhesion molecule-1 (MAdCAM-1), the MAdCAM-1-binding site is close to, or overlapping with, VCAM-1- and CS-1-binding sites. The role of Asp-130 of β1 in the binding to VCAM-1 and CS-1 peptide was examined. Chinese hamster ovary (CHO) cells expressing β1(D130A) (Asp-130 to Ala mutant of β1) and α4 showed much less binding to both ligands than CHO cells expressing wild-type β1 and α4 [a dominant negative effect of β1(D130A)], suggesting that Asp-130 of β1 is critical for binding to both ligands and that the two ligands share common binding mechanisms.

Original languageEnglish (US)
Pages (from-to)945-951
Number of pages7
JournalBiochemical Journal
Volume305
Issue number3
StatePublished - 1995
Externally publishedYes

Fingerprint

Integrin alpha4beta1
Integrins
Epitopes
Binding Sites
Ligands
Vascular Cell Adhesion Molecule-1
Monoclonal Antibodies
Cells
Cell Adhesion Molecules
Cricetulus
Ovary
Agglomeration
Cations
Peptides

ASJC Scopus subject areas

  • Biochemistry

Cite this

Identification of putative ligand-binding sites of the integrin α4β1 (VLA-4, CD49d/CD29). / Kamata, T.; Puzon, W.; Takada, Yoshikazu.

In: Biochemical Journal, Vol. 305, No. 3, 1995, p. 945-951.

Research output: Contribution to journalArticle

@article{6ce1bbda789846b78f4d17a8b5737bc6,
title = "Identification of putative ligand-binding sites of the integrin α4β1 (VLA-4, CD49d/CD29)",
abstract = "Integrin α4β1 recognizes both fibronectin (CS-1 sequence) and vascular cell adhesion molecule-1 (VCAM-1). To localize the ligand-binding sites of α4, we located the epitopes for function-blocking anti-α4 monoclonal antibodies (mAbs), including those that recognize previously described (but not yet physically localized) functional epitopes (A, B1, B2 and C) using interspecies α4 chimeras expressed in mammalian cells. Epitopes B1 and B2 were associated with ligand binding, and epitopes A and B2 with homotypic cellular aggregation, mAbs P4C2 (epitope B2), 20E4 and PS/2 were mapped within residues 108-182; mAbs HP2/1 (epitope B1), SG/73 and R1-2 within residues 195-268; mAbs HP1/3 (epitope A) and P4G9 within residues 1-38; and B5G10 (epitope C) within residues 269-548. The data suggest that residues 108-268, which do not include bivalent-cation-binding motifs, are related to VCAM-1 and CS-1 binding, and more N-terminal portions of α4 (residues 1-38 and 108-182) to homotypic aggregation. Since mAbs PS/2 and HP2/1 block α4β7 binding to mucosal addressin cell adhesion molecule-1 (MAdCAM-1), the MAdCAM-1-binding site is close to, or overlapping with, VCAM-1- and CS-1-binding sites. The role of Asp-130 of β1 in the binding to VCAM-1 and CS-1 peptide was examined. Chinese hamster ovary (CHO) cells expressing β1(D130A) (Asp-130 to Ala mutant of β1) and α4 showed much less binding to both ligands than CHO cells expressing wild-type β1 and α4 [a dominant negative effect of β1(D130A)], suggesting that Asp-130 of β1 is critical for binding to both ligands and that the two ligands share common binding mechanisms.",
author = "T. Kamata and W. Puzon and Yoshikazu Takada",
year = "1995",
language = "English (US)",
volume = "305",
pages = "945--951",
journal = "Biochemical Journal",
issn = "0264-6021",
publisher = "Portland Press Ltd.",
number = "3",

}

TY - JOUR

T1 - Identification of putative ligand-binding sites of the integrin α4β1 (VLA-4, CD49d/CD29)

AU - Kamata, T.

AU - Puzon, W.

AU - Takada, Yoshikazu

PY - 1995

Y1 - 1995

N2 - Integrin α4β1 recognizes both fibronectin (CS-1 sequence) and vascular cell adhesion molecule-1 (VCAM-1). To localize the ligand-binding sites of α4, we located the epitopes for function-blocking anti-α4 monoclonal antibodies (mAbs), including those that recognize previously described (but not yet physically localized) functional epitopes (A, B1, B2 and C) using interspecies α4 chimeras expressed in mammalian cells. Epitopes B1 and B2 were associated with ligand binding, and epitopes A and B2 with homotypic cellular aggregation, mAbs P4C2 (epitope B2), 20E4 and PS/2 were mapped within residues 108-182; mAbs HP2/1 (epitope B1), SG/73 and R1-2 within residues 195-268; mAbs HP1/3 (epitope A) and P4G9 within residues 1-38; and B5G10 (epitope C) within residues 269-548. The data suggest that residues 108-268, which do not include bivalent-cation-binding motifs, are related to VCAM-1 and CS-1 binding, and more N-terminal portions of α4 (residues 1-38 and 108-182) to homotypic aggregation. Since mAbs PS/2 and HP2/1 block α4β7 binding to mucosal addressin cell adhesion molecule-1 (MAdCAM-1), the MAdCAM-1-binding site is close to, or overlapping with, VCAM-1- and CS-1-binding sites. The role of Asp-130 of β1 in the binding to VCAM-1 and CS-1 peptide was examined. Chinese hamster ovary (CHO) cells expressing β1(D130A) (Asp-130 to Ala mutant of β1) and α4 showed much less binding to both ligands than CHO cells expressing wild-type β1 and α4 [a dominant negative effect of β1(D130A)], suggesting that Asp-130 of β1 is critical for binding to both ligands and that the two ligands share common binding mechanisms.

AB - Integrin α4β1 recognizes both fibronectin (CS-1 sequence) and vascular cell adhesion molecule-1 (VCAM-1). To localize the ligand-binding sites of α4, we located the epitopes for function-blocking anti-α4 monoclonal antibodies (mAbs), including those that recognize previously described (but not yet physically localized) functional epitopes (A, B1, B2 and C) using interspecies α4 chimeras expressed in mammalian cells. Epitopes B1 and B2 were associated with ligand binding, and epitopes A and B2 with homotypic cellular aggregation, mAbs P4C2 (epitope B2), 20E4 and PS/2 were mapped within residues 108-182; mAbs HP2/1 (epitope B1), SG/73 and R1-2 within residues 195-268; mAbs HP1/3 (epitope A) and P4G9 within residues 1-38; and B5G10 (epitope C) within residues 269-548. The data suggest that residues 108-268, which do not include bivalent-cation-binding motifs, are related to VCAM-1 and CS-1 binding, and more N-terminal portions of α4 (residues 1-38 and 108-182) to homotypic aggregation. Since mAbs PS/2 and HP2/1 block α4β7 binding to mucosal addressin cell adhesion molecule-1 (MAdCAM-1), the MAdCAM-1-binding site is close to, or overlapping with, VCAM-1- and CS-1-binding sites. The role of Asp-130 of β1 in the binding to VCAM-1 and CS-1 peptide was examined. Chinese hamster ovary (CHO) cells expressing β1(D130A) (Asp-130 to Ala mutant of β1) and α4 showed much less binding to both ligands than CHO cells expressing wild-type β1 and α4 [a dominant negative effect of β1(D130A)], suggesting that Asp-130 of β1 is critical for binding to both ligands and that the two ligands share common binding mechanisms.

UR - http://www.scopus.com/inward/record.url?scp=0028900673&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028900673&partnerID=8YFLogxK

M3 - Article

VL - 305

SP - 945

EP - 951

JO - Biochemical Journal

JF - Biochemical Journal

SN - 0264-6021

IS - 3

ER -